These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11336604)

  • 1. Applications of pharmacogenetics in psychiatry: personalisation of treatment.
    Arranz MJ; Munro J; Osborne S; Collier D; Kerwin RW
    Expert Opin Pharmacother; 2001 Apr; 2(4):537-42. PubMed ID: 11336604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment.
    Arranz MJ; Kerwin RW
    Ann Med; 2000 Mar; 32(2):128-33. PubMed ID: 10766404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
    Kirchheiner J; Nickchen K; Bauer M; Wong ML; Licinio J; Roots I; Brockmöller J
    Mol Psychiatry; 2004 May; 9(5):442-73. PubMed ID: 15037866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism.
    Vandel P; Talon JM; Haffen E; Sechter D
    Curr Pharm Des; 2007; 13(2):241-50. PubMed ID: 17269931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics for the individualization of psychiatric treatment.
    Arranz MJ; Collier D; Kerwin RW
    Am J Pharmacogenomics; 2001; 1(1):3-10. PubMed ID: 12173312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
    Quaranta S; Dupouey J; Colle R; Verstuyft C
    Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress on pharmacogenetic study in psychiatry and future prospects of order-made drug therapy for mental disorders].
    Shimoda K
    Seishin Shinkeigaku Zasshi; 2009; 111(12):1546-51. PubMed ID: 20344870
    [No Abstract]   [Full Text] [Related]  

  • 8. Personalized pharmacotherapy in psychiatry.
    Filaković P; Petek A
    Psychiatr Danub; 2009 Sep; 21(3):341-6. PubMed ID: 19794353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of CYP2D6 genotyping in psychiatry.
    Loovers HM; van der Weide J
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1065-77. PubMed ID: 19572825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Current issues in clinical implementation.
    de Leon J
    CNS Spectr; 2006 Mar; 11(3 Suppl 3):8-12. PubMed ID: 17760224
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales.
    Sistonen J; Fuselli S; Palo JU; Chauhan N; Padh H; Sajantila A
    Pharmacogenet Genomics; 2009 Feb; 19(2):170-9. PubMed ID: 19151603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
    Psychiatr Danub; 2010 Jun; 22(2):335-7. PubMed ID: 20562776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of cardiovascular pharmacogenetics.
    Voora D; Ginsburg GS
    J Am Coll Cardiol; 2012 Jul; 60(1):9-20. PubMed ID: 22742397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenetics/pharmacogenomics in psychiatry].
    Ueda M; Ishiguro S; Watanabe T; Saeki Y; Shimoda K
    Nihon Rinsho; 2010 Jan; 68(1):155-62. PubMed ID: 20077810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.
    de Leon J; Armstrong SC; Cozza KL
    Psychosomatics; 2006; 47(1):75-85. PubMed ID: 16384813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic.
    Müller DJ; Kekin I; Kao AC; Brandl EJ
    Int Rev Psychiatry; 2013 Oct; 25(5):554-71. PubMed ID: 24151801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic polymorphism of CYP-450 in drug development].
    Nonen S; Azuma J
    Nihon Yakurigaku Zasshi; 2009 Oct; 134(4):212-5. PubMed ID: 19828926
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disorders.
    Kirchheiner J; Rodriguez-Antona C
    CNS Drugs; 2009; 23(3):181-91. PubMed ID: 19320528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.